Savara, Inc. (SVRA)
5.61
+0.03
(+0.54%)
USD |
NASDAQ |
Apr 02, 12:53
Savara Research and Development Expense (TTM) : 81.40M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 171.65M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Imunon, Inc. | 7.781M |